Publicaciones en colaboración con investigadores/as de University of Genoa (9)

2021

  1. Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium survey

    International Journal of Geriatric Psychiatry, Vol. 36, Núm. 2, pp. 324-333

2020

  1. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

    The Lancet Neurology, Vol. 19, Núm. 11, pp. 951-962

2019

  1. Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC)

    NeuroImage: Clinical, Vol. 23

2018

  1. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus

    European Journal of Neurology, Vol. 25, Núm. 10, pp. 1201-1217

  2. Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1557-1566

  3. Clinical utility of FDG-PET for the clinical diagnosis in MCI

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1497-1508

  4. Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington’s disease

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1546-1556

2013

  1. Appropriate use criteria for amyloid PET imaging cannot replace guidelines: On behalf of the European Association of Nuclear Medicine

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Núm. 7, pp. 1122-1125

2007

  1. Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of Multiple Sclerosis

    Journal of Neuroimmunology